SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921530-03-000007
Filing Date
2003-01-08
Accepted
2003-01-08 17:28:50
Documents
1
Group Members
FRANK H. PEARLGEORGE SOROSPERSEUS BIOTECH FUND PARTNERS, LLCPERSEUS-SOROS BIOPHARMACEUTICAL FUND, L.P.PERSEUS-SOROS PARTNERS, LLCPERSEUSPUR, LLCPERSUS EC, LLCSFM AH, INC.SFM PARTICIPATION, L.P.SOROS FUND MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 sch13da1_122702.txt SC 13D/A 42414
  Complete submission text file 0000921530-03-000007.txt   44895
Mailing Address ONE ROCKEFELLER PLAZA SUITE 1600 NEW YORK NY 10020
Business Address ONE ROCKEFELLER PLAZA SUITE 1600 NEW YORK NY 10020 2124456581
BIOENVISION INC (Subject) CIK: 0001028205 (see all company filings)

IRS No.: 113375915 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-78274 | Film No.: 03508343
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKIN, GUMP, STRAUSS,HAUER,FELD, 399 PARK AVENUE NEW YORK NY 10022
Business Address 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 2128721054
SOROS FUND MANAGEMENT LLC (Filed by) CIK: 0001029160 (see all company filings)

IRS No.: 133914976 | State of Incorp.: DE | Fiscal Year End: 1231